Company Overview
Snapshot
Founded in January 2022, HVT Medical operates with 1–10 employees. The company has raised $1.5 million across two funding rounds, with Israel MedicUp participating. HVT Medical is developing the Splitter device, an advanced transcatheter aortic valve implantation device designed to address anatomical limitations for patients.
Business overview
HVT Medical is a Health Tech & Life Sciences company focused on developing solutions for patients contraindicated for aortic valve implantation due to anatomical limitations. The company's core product, the Splitter device, is designed to be inserted via a catheterization procedure to modify the aortic valve, enabling safer transcatheter valve implantation. This device performs cusp splitting before a TAVI procedure to reduce the risk of coronary occlusion by creating an intentional laceration or excision of valve cusp tissue using an advanced catheter with a cutting head. HVT Medical operates within the Medical Devices, Medical Treatment & Therapeutics sectors, serving the Healthcare & Life Sciences industry, specifically targeting the Medical Devices Industry and Medical Equipment market.
Company Intelligence Q&A
- What is HVT Medical's primary focus?
- HVT Medical is focused on developing solutions for patients who are contraindicated for aortic valve implantation due to anatomical limitations, specifically through its Splitter device.
- What is the Splitter device?
- The Splitter is a device developed by HVT Medical that can be inserted in a catheterization procedure to modify the aortic valve, enabling safe transcatheter valve implantation. It performs cusp splitting before a TAVI procedure to reduce the risk of coronary occlusion.
- When was HVT Medical founded?
- HVT Medical was founded in January 2022.
- What is the current product stage of the Splitter device?
- The Splitter device is currently in its Beta product stage, as of August 2026.
- Which organization provided a grant to HVT Medical?
- In January 2024, HVT Medical secured a grant from the Israel Innovation Authority.